• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Hyundai Bioscience Plans Phase 3 Trial For High-Risk COVID-19 Patients

    PR NEWSWIRE

    ADM Korea Targets Prostate Cancer For Niclosamide-Based Drug Trial

    PR NEWSWIRE

    Hyundai develops multi-treatment for mosquito-borne viral infections

    PR NEWSWIRE

    Korean firm Hyundai Bioscience soon to initiate global clinical development

    BIOSPECTRUM ASIA

    Hyundai Bioscience announces that "Xafty is the only antiviral that can be immediately used for the treatment of Dengue fever

    PR NEWSWIRE

    Hyundai Bioscience announced positive phase 2 clinical study results

    PR NEWSWIRE

    Chemotherapy may be completed within 8 days with two doses of Polytaxel

    PRNEWSWIRE

    Hyundai Bioscience in talks for phase 1 study of polytaxel in Australia

    FIRSTWORDPHARMA

    Hyundai to submit fast track processing request to FDA for monkeypox drug

    PHARMACEUTICAL-TECHNOLOGY

    Hyundai Bioscience launches Phase II clinical trial of Covid-19 drug

    CLINICALTRIALSARENA

    Hyundai Bioscience finds combination therapy effective against Covid-19

    PHARMACEUTICAL-TECHNOLOGY

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.